Recap: CASI Pharmaceuticals Q4 Earnings

CASI Pharmaceuticals CASI reported its Q4 earnings results on Thursday, March 28, 2024 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

CASI Pharmaceuticals missed estimated earnings by -88.0%, reporting an EPS of $-0.45 versus an estimate of $-0.24.

Revenue was down $8.38 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.21 which was followed by a 3.0% drop in the share price the next day.

Here's a look at CASI Pharmaceuticals's past performance:

To track all earnings releases for CASI Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.